View Older Stories View More Recent Stories

Nov 16, 2020 04:13PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 13, 2020 08:00AM PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Nov 13, 2020 08:00AM PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Nov 12, 2020 05:15PM Form SC 13D/A Aerpio Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Nov 11, 2020 09:00AM Edgewise Therapeutics Initiates Phase 1 Clinical Trial of EDG-5506 in Becker Muscular Dystrophy
Nov 9, 2020 08:02AM Ikena Oncology to Present New Preclinical Data on AHR Antagonist IK-175 at the Society for Immunotherapy of Cancer’s 2020 Annual Meeting
Nov 6, 2020 05:13PM Form SC 13D Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 5, 2020 04:05PM Natera Reports Third Quarter 2020 Financial Results
Nov 4, 2020 08:01PM Form 4 Galecto, Inc. For: Nov 02 Filed by: ORBIMED ADVISORS LLC
Nov 2, 2020 11:07AM Petrichor Closes Oversubscribed Fund I at $410 Million
Oct 29, 2020 09:00AM Edgewise Therapeutics Appoints John Moore as General Counsel
Oct 29, 2020 07:00AM Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Oct 28, 2020 09:13PM Form 3 Galecto Inc. For: Oct 28 Filed by: ORBIMED ADVISORS LLC
Oct 27, 2020 09:09AM Steven Yecies Joins Javelin Oncology as Chief Executive Officer
Oct 25, 2020 09:48AM 5 Biotech Penny Stocks To Watch With Recent & Upcoming Events
Oct 23, 2020 06:02AM Form SC 13D/A BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC
Oct 22, 2020 09:00AM Edgewise Therapeutics Appoints Behrad Derakhshan as Chief Business Officer
Oct 22, 2020 08:00AM Inspire Medical Systems, Inc. Announces Appointment of Seasoned Senior Corporate Executive Shelley Broader to its Board of Directors
Oct 16, 2020 09:00AM Edgewise Therapeutics Appoints Michael Carruthers as Chief Financial Officer
Oct 14, 2020 06:02AM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
Oct 7, 2020 05:08PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Oct 6, 2020 05:17PM Form SC 13D/A LogicBio Therapeutics, Filed by: ORBIMED ADVISORS LLC
Oct 6, 2020 04:05PM Arcutis Biotherapeutics Announces Closing of Public Offering and Concurrent Private Placement of Common Stock
Oct 5, 2020 05:28PM Form SC 13D GRAYBUG VISION, INC. Filed by: ORBIMED ADVISORS LLC
Oct 5, 2020 05:27PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Oct 5, 2020 05:23PM Form SC 13D PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Oct 5, 2020 05:18PM Form SC 13D Prelude Therapeutics Filed by: ORBIMED ADVISORS LLC
Oct 5, 2020 04:14PM Form 4 Xtant Medical Holdings, For: Oct 01 Filed by: ORBIMED ADVISORS LLC
Oct 5, 2020 09:00AM Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement Financing
Oct 5, 2020 07:25AM Corvus Pharmaceuticals (CRVS) Announces Co-Founding of Angel Pharmaceuticals in China
Oct 5, 2020 07:24AM Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
Oct 2, 2020 06:11AM Arcutis Biotherapeutics Inc. (ARQT) Prices 4M Share Common Offering and Concurrent Private Placement
Oct 1, 2020 10:47PM Arcutis Biotherapeutics Announces Pricing of Public Offering and Concurrent Private Placement of Common Stock
Oct 1, 2020 04:05PM Xtant Medical Announces Closing of Debt Restructuring
Sep 30, 2020 07:54PM Form 4/A Prelude Therapeutics For: Mar 27 Filed by: ORBIMED ADVISORS LLC
Sep 29, 2020 08:11PM Form 4 Prelude Therapeutics For: Sep 25 Filed by: ORBIMED ADVISORS LLC
Sep 29, 2020 04:52PM Arcutis Bio (ARQT) Announces 4M Share Proposed Public Offering and Concurrent $35M Private Placement of Common Stock
Sep 29, 2020 04:51PM Arcutis Biotherapeutics Announces Proposed Public Offering and Concurrent Private Placement of Common Stock
Sep 29, 2020 04:41PM Form 4 GRAYBUG VISION, INC. For: Sep 25 Filed by: ORBIMED ADVISORS LLC
Sep 25, 2020 02:00AM Lysogene Reports First Half 2020 Financial Results and Provides Operational Update
Sep 24, 2020 07:30PM Form 3 GRAYBUG VISION, INC. For: Sep 24 Filed by: ORBIMED ADVISORS LLC
Sep 24, 2020 07:25PM Form 3 Prelude Therapeutics For: Sep 24 Filed by: ORBIMED ADVISORS LLC
Sep 23, 2020 05:10PM Form 4 89bio, Inc. For: Sep 21 Filed by: OrbiMed Advisors Israel II Ltd
Sep 23, 2020 05:01PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 23, 2020 08:00AM Silverback Therapeutics Raises $85 Million in Series C Financing; Company Announces Executive Promotions
Sep 21, 2020 09:00AM Novellus Closes $57M Series C Financing
Sep 18, 2020 05:13PM Form SC 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 17, 2020 09:46PM Form 4 Adicet Bio, Inc. For: Sep 15 Filed by: ORBIMED ADVISORS LLC
Aug 31, 2020 07:30AM NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNS® System for Refractory Epilepsy
Aug 28, 2020 04:15PM Sinovac Reports Unaudited Second Quarter 2020 Financial Results
View More Recent Stories View Older Stories